Literature DB >> 28432183

Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins.

Amanda L Brown1, J Mark Brown1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28432183      PMCID： PMC5454498          DOI： 10.1194/jlr.C077131

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  24 in total

1.  Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2016-01-26       Impact factor: 29.690

2.  Cholesterol ester exchange between human plasma high and low density lipoproteins mediated by a plasma protein factor.

Authors:  A Sniderman; B Teng; C Vezina; Y L Marcel
Journal:  Atherosclerosis       Date:  1978-11       Impact factor: 5.162

3.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 4.  Cholesteryl ester transfer protein inhibitors: challenges and perspectives.

Authors:  T D Filippatos; E Klouras; F Barkas; M Elisaf
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-28

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.

Authors:  K Takahashi; X C Jiang; N Sakai; S Yamashita; K Hirano; H Bujo; H Yamazaki; J Kusunoki; T Miura; P Kussie
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.

Authors:  X C Jiang; L B Agellon; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 8.  Clinical trials with cholesteryl ester transfer protein inhibitors.

Authors:  Belinda A Di Bartolo; MyNgan Duong; Stephen J Nicholls
Journal:  Curr Opin Lipidol       Date:  2016-12       Impact factor: 4.776

9.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.

Authors:  K R Marotti; C K Castle; T P Boyle; A H Lin; R W Murray; G W Melchior
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

10.  Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.

Authors:  John S Millar; Michael E Lassman; Tiffany Thomas; Rajasekhar Ramakrishnan; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Soumia Aoujil; Taylor Standiford; David E Gutstein; Henry N Ginsberg; Daniel J Rader; Gissette Reyes-Soffer
Journal:  J Lipid Res       Date:  2017-03-17       Impact factor: 5.922
View more
  1 in total

Review 1.  Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?

Authors:  Theodosios D Filippatos; Anastazia Kei; Moses S Elisaf
Journal:  Diseases       Date:  2017-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.